Search Within

Mark Kris

  1. "Surgery"
Formats
  1. Meeting Abstract (90)
  2. Journal Article (86)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Department of Medicine (178)
  2. Solid Tumor Oncology Division (178)
  3. Surgery (178)
  4. Thoracic Oncology (178)
  5. Department of Pathology and Laboratory Medicine (92)
  6. Epidemiology and Biostatistics (59)

More Groups

People
  1. Valerie Rusch (130)
  2. Jamie Chaft (51)
  3. William Travis (43)
  4. Gregory Riely (41)
  5. Maureen Zakowski (41)
  6. Marc Ladanyi (40)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (4)
  4. 2022 (9)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (47)
  2. Journal of Thoracic Oncology (46)
  3. Annals of Thoracic Surgery (7)
  4. Clinical Cancer Research (7)
  5. Journal of Thoracic and Cardiovascular Surgery (7)
  6. Lung Cancer (6)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. American Society of Clinical Oncology (49)
  3. American Association for Cancer Research (17)
  4. Elsevier Science, Inc. (10)
  5. Nature Publishing Group (9)
  6. Mosby Elsevier (7)

More Publishers

Results (178)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • LCMC3: Clinical utility of SUVmax on preoperative 18F-FDG PET-CT in resectable NSCLC treated with neoadjuvant atezolizumab
    Meeting Abstract

    Merritt, R.; Patterson, G. A.; Toloza, E. M.; Lee, J. M.; Raz, D. J.; Baciewicz, F.; Weyant, M.; Molena, D.; Isbell, J.; Kim, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • LCMC3: Long-term disease-free and overall survival and their association with ctDNA after neoadjuvant atezolizumab for NSCLC
    Meeting Abstract

    Owen, D. H.; Chaft, J. E.; Haura, E. B.; Toloza, E.; Waqar, S. N.; Patterson, G. A.; Finley, D.; Blasberg, J.; Raz, D.; Salgia, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary results of the Lung Cancer Mutation Consortium LCMC4 evaluation of actionable drivers in early stage lung cancer (LEADER) screening trial
    Meeting Abstract

    Chaft, J. E.; Swanson, S.; Lee, J. M.; Lin, J.; Tsukada, H.; Li, T.; Ripley, R. T.; Kaifi, J. T.; Baik, C. S.; Bunn, P. A. Jr.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Artificial intelligence–powered assessment of pathologic response to neoadjuvant atezolizumab in patients with NSCLC: Results from the LCMC3 study
    Journal Article

    Dacic, S.; Travis, W. D.; Giltnane, J. M.; Kos, F.; Abel, J.; Hilz, S.; Fujimoto, J.; Sholl, L.; Ritter, J.; Khalil, F.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study
    Meeting Abstract

    Presley, C.; Owen, D. H.; Nicholas, A.; Hilz, S.; Oezkan, F.; Chaft, J. E.; Toloza, E. M.; Haura, E. B.; Patterson, A.; Waqar, S. N.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save